These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 11493453)

  • 61. Prevention of graft-versus-host disease and bone marrow rejection: kinetics of induction of tolerance by UVB modulation of accessory cells and T cells in the bone marrow inoculum.
    Oluwole SF; Engelstad K; James T
    Blood; 1993 Mar; 81(6):1658-65. PubMed ID: 8453111
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Induction of peripheral T cell tolerance by antigen-presenting B cells. II. Chronic antigen presentation overrules antigen-presenting B cell activation.
    Raimondi G; Zanoni I; Citterio S; Ricciardi-Castagnoli P; Granucci F
    J Immunol; 2006 Apr; 176(7):4021-8. PubMed ID: 16547237
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
    Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
    Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Deletion, but not anergy, is involved in TGF-beta-treated antigen-presenting cell-induced tolerance.
    Alard P; Clark SL; Kosiewicz MM
    Int Immunol; 2003 Aug; 15(8):945-53. PubMed ID: 12882832
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Intercellular exchange of class II major histocompatibility complex/peptide complexes is a conserved process that requires activation of T cells but is constitutive in other types of antigen presenting cell.
    Patel DM; Mannie MD
    Cell Immunol; 2001 Dec; 214(2):165-72. PubMed ID: 12088415
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens.
    Lenz LL; Butz EA; Bevan MJ
    J Exp Med; 2000 Oct; 192(8):1135-42. PubMed ID: 11034603
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Incomplete differentiation of antigen-specific CD8 T cells in tumor-draining lymph nodes.
    Hargadon KM; Brinkman CC; Sheasley-O'neill SL; Nichols LA; Bullock TN; Engelhard VH
    J Immunol; 2006 Nov; 177(9):6081-90. PubMed ID: 17056534
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immune tolerance to self-major histocompatibility complex class II antigens after bone marrow transplantation: role of regulatory T cells.
    Hess AD; Thoburn CJ
    Biol Blood Marrow Transplant; 2006 May; 12(5):518-29. PubMed ID: 16635787
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification and characterization of the antigen presenting cell in rat autoimmune myocarditis: evidence of bone marrow derivation and non-requirement for MHC class I compatibility with pathogenic T cells.
    Ratcliffe NR; Wegmann KW; Zhao RW; Hickey WF
    J Autoimmun; 2000 Nov; 15(3):369-79. PubMed ID: 11040077
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Normal hematopoiesis is maintained by activated bone marrow CD4+ T cells.
    Monteiro JP; Benjamin A; Costa ES; Barcinski MA; Bonomo A
    Blood; 2005 Feb; 105(4):1484-91. PubMed ID: 15514013
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Intrahepatic Cross-Presentation and Hepatocellular Antigen Presentation Play Distinct Roles in the Induction of Hepatitis B Virus-Specific CD8
    Murata Y; Kawashima K; Sheikh K; Tanaka Y; Isogawa M
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30089700
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comprehensive Analysis of the Activation and Proliferation Kinetics and Effector Functions of Human Lymphocytes, and Antigen Presentation Capacity of Antigen-Presenting Cells in Xenogeneic Graft-Versus-Host Disease.
    Kawasaki Y; Sato K; Hayakawa H; Takayama N; Nakano H; Ito R; Mashima K; Oh I; Minakata D; Yamasaki R; Morita K; Ashizawa M; Yamamoto C; Hatano K; Fujiwara SI; Ohmine K; Muroi K; Kanda Y
    Biol Blood Marrow Transplant; 2018 Aug; 24(8):1563-1574. PubMed ID: 29678638
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Molecular modification of idiotypes from B-cell lymphomas for expression in mature dendritic cells as a strategy to induce tumor-reactive CD4+ and CD8+ T-cell responses.
    Muraro S; Bondanza A; Bellone M; Greenberg PD; Bonini C
    Blood; 2005 May; 105(9):3596-604. PubMed ID: 15650058
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Trioma-based vaccination against B-cell lymphoma confers long-lasting tumor immunity.
    Mocikat R; Selmayr M; Thierfelder S; Lindhofer H
    Cancer Res; 1997 Jun; 57(12):2346-9. PubMed ID: 9192805
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impact of the lymphoma idiotype on in vivo tumor protection in a vaccination model based on targeting antigens to antigen-presenting cells.
    Kronenberger K; Dieckmann A; Selmayr M; Strehl J; Wahl U; Lindhofer H; Kraal G; Mocikat R
    Blood; 2002 Feb; 99(4):1327-31. PubMed ID: 11830483
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bispecific antibodies target operationally tumor-specific antigens in two leukemia relapse models.
    Lindhofer H; Menzel H; Günther W; Hültner L; Thierfelder S
    Blood; 1996 Dec; 88(12):4651-8. PubMed ID: 8977258
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells.
    Serafini P; Mgebroff S; Noonan K; Borrello I
    Cancer Res; 2008 Jul; 68(13):5439-49. PubMed ID: 18593947
    [TBL] [Abstract][Full Text] [Related]  

  • 78. T lymphocytes from irradiation chimeras repopulated with 13-day fetal liver cells recognize antigens only in association with self-MHC products.
    Nisbet-Brown E; Diener E
    J Mol Cell Immunol; 1986; 2(4):235-42. PubMed ID: 2908177
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Purified donor T cells alone activate transplantation immunity to the male antigen but induce tolerance in combination with Mac-1+ donor cells.
    Sheng B; McCormack WT; Smith RT
    Transplantation; 1999 Oct; 68(7):1024-9. PubMed ID: 10532545
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens.
    Huang AY; Golumbek P; Ahmadzadeh M; Jaffee E; Pardoll D; Levitsky H
    Science; 1994 May; 264(5161):961-5. PubMed ID: 7513904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.